OR WAIT null SECS
January 02, 2022
January is the kind of month that can make your head spin.
December 02, 2021
Pharma and biotech are ruling the roost in terms of university innovation, but European spinouts are still experiencing barriers to long-term success.
We have broken rules, invented new ones, and engineered stronger institutions and supply chains that will serve us better going forward.
November 02, 2021
Manufacturing capacity expansion is high on the agenda for many bio/pharma companies and service providers in Europe.
October 02, 2021
Change of roster does not change the goal line. We are all patients first.
September 02, 2021
While the players may change, pharma’s patients-first focus should not.
August 02, 2021
Excessive drug pricing is being scrutinized across Europe, as hefty fines are set to send out a clear message of intolerance to anti-competition conduct.
Congress questions FDA on plans to catch up and move forward with facility inspections.